Pernicious anemia revisited (Q40814824)

24 September 2017

1 reference

title

Pernicious anemia revisited (English)

1 reference

24 September 2017

1 reference

2

A Tefferi

1 reference

24 September 2017

R K Pruthi

1

1 reference

PubMed ID

8309266

24 September 2017

language of work or name

English

0 references

publication date

1 February 1994

1 reference

24 September 2017

1 reference

24 September 2017

69

1 reference

24 September 2017

2

1 reference

24 September 2017

144-150

1 reference

Racial patterns in pernicious anemia. Early age at onset and increased frequency of intrinsic-factor antibody in black women

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Vitamin B-12: plant sources, requirements, and assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Inhibitory effect of eggs on vitamin B12 absorption: description of a simple ovalbumin 57Co-vitamin B12 absorption test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

The 1986 Herman award lecture. Nutrition science as a continually unfolding story: the folate and vitamin B-12 paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Effect of proteolytic enzymes on the binding of cobalamin to R protein and intrinsic factor. In vitro evidence that a failure to partially degrade R protein is responsible for cobalamin malabsorption in pancreatic insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Cobalamin malabsorption due to nondegradation of R proteins in the human intestine. Inhibited cobalamin absorption in exocrine pancreatic dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

A dual mechanism of vitamin B12 plasma absorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

The neuropsychiatry of megaloblastic anaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Pernicious anemia and subsequent cancer. A population-based cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Pernicious anemia as a risk factor in gastric cancer. The extent of the problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Risk of development of gastric carcinoma in patients with pernicious anemia: a population-based study in Rochester, Minnesota.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Mucosal argyrophil endocrine cells in pernicious anaemia and upper gastrointestinal carcinoid tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

A qualitative platelet defect in severe vitamin B 12 deficiency. Response, hyperresponse, and thrombosis after vitamin B 12 therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Diagnosis of megaloblastic anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Cobalamin Analogues Are Present in Human Plasma and Can Mask Cobalamin Deficiency because Current Radioisotope Dilution Assays Are Not Specific for True Cobalamin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Screening elderly populations for cobalamin (vitamin B12) deficiency using the urinary methylmalonic acid assay by gas chromatography mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Neonatal Megaloblastic Anemia Due to Inherited Transcobalamin II Deficiency in Two Siblings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Coexistence of pernicious anaemia and chronic myeloid leukaemia: an experiment of nature involving vitamin B12 metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Incidence and pathogenesis of megaloblastic erythropoiesis in multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Abnormal vitamin B12 metabolism in human immunodeficiency virus infection. Association with neurological dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Methylmalonic acid excretion: an index of vitamin-B12 deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Methylmalonic acid excretion studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Value of estimating methylamalonic acid excretion in anaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Diagnosis of cobalamin deficiency I: usefulness of serum methylmalonic acid and total homocysteine concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Assay of methylmalonic acid in the serum of patients with cobalamin deficiency using capillary gas chromatography-mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Intrinsic-factor-inhibiting substance in serum of orally treated patients with pernicious anaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Intrinsic factor antibody tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Intrinsic-factor antibodies in absence of pernicious anaemia. 3-7 year follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Correctable Intestinal Defect of Vitamin B_12 Absorption in Pernicious Anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

The serum pepsinogen level with special reference to the histology of the gastric mucosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

An appraisal of tests for severe atrophic gastritis in relatives of patients with pernicious anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Pepsinogens and other serum markers in pernicious anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Gastric Morphology, Function, and Immunology in First-degree Relatives of Probands with Pernicious Anemia and Controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Gastric morphology and serum gastrin levels in pernicious anaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Low holotranscobalamin II is the earliest serum marker for subnormal vitamin B12 (cobalamin) absorption in patients with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

New assay for the rapid determination of plasma holotranscobalamin II levels: preliminary evaluation in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Bone-Marrow in the Treatment of Pernicious Anaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Oral treatment of pernicious anemia with vitamin B12 without intrinsic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Long-term trial of oral vitamin B12 in pernicious anaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Oral vitamin B12 without intrinsic factor in the treatment of pernicious anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

7 January 2021

Vitamin B 12 injections.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Intranasal cyanocobalamin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Time Dependency of Cognitive Recovery with Cobalamin Replacement: Report or a Pilot Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

Neurologic Aspects of Cobalamin Deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Pernicious anaemia as a risk factor in gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Oral treatment of pernicious anemia with high doses of vitamin B12 without intrinsic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961041-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-6196(12)61041-6

1 reference

24 September 2017

1 reference

PubMed ID

8309266